Bioventus Begin Period Cash Flow vs Ev To Free Cash Flow Analysis

BVS Stock  USD 11.42  0.32  2.88%   
Bioventus financial indicator trend analysis is way more than just evaluating Bioventus prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Bioventus is a good investment. Please check the relationship between Bioventus Begin Period Cash Flow and its Ev To Free Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioventus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.

Begin Period Cash Flow vs Ev To Free Cash Flow

Begin Period Cash Flow vs Ev To Free Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Bioventus Begin Period Cash Flow account and Ev To Free Cash Flow. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Bioventus' Begin Period Cash Flow and Ev To Free Cash Flow is -0.02. Overlapping area represents the amount of variation of Begin Period Cash Flow that can explain the historical movement of Ev To Free Cash Flow in the same time period over historical financial statements of Bioventus, assuming nothing else is changed. The correlation between historical values of Bioventus' Begin Period Cash Flow and Ev To Free Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Begin Period Cash Flow of Bioventus are associated (or correlated) with its Ev To Free Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Ev To Free Cash Flow has no effect on the direction of Begin Period Cash Flow i.e., Bioventus' Begin Period Cash Flow and Ev To Free Cash Flow go up and down completely randomly.

Correlation Coefficient

-0.02
Relationship DirectionNegative 
Relationship StrengthInsignificant

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Ev To Free Cash Flow

A valuation metric comparing the company's enterprise value to its free cash flow, used to evaluate whether a company is undervalued or overvalued.
Most indicators from Bioventus' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Bioventus current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bioventus. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For more information on how to buy Bioventus Stock please use our How to Invest in Bioventus guide.Enterprise Value is likely to gain to about 1.2 B in 2024, whereas Discontinued Operations is likely to drop (2.2 M) in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense1.1M25.8M40.7M42.7M
Depreciation And Amortization38.7M61.4M57.4M40.7M

Bioventus fundamental ratios Correlations

0.760.880.780.80.50.87-0.150.82-0.730.780.240.7-0.290.240.83-0.34-0.670.770.870.710.920.790.970.820.63
0.760.930.930.940.860.860.170.9-0.220.90.130.99-0.480.130.870.11-0.660.980.860.930.860.970.60.820.65
0.880.930.90.930.670.940.00.97-0.490.940.170.88-0.430.170.93-0.11-0.650.940.980.870.920.940.770.890.67
0.780.930.90.980.660.890.110.84-0.360.90.30.89-0.560.30.89-0.11-0.560.940.870.810.820.960.640.870.66
0.80.940.930.980.650.890.040.87-0.420.940.260.9-0.610.260.91-0.15-0.550.970.890.790.820.980.650.880.74
0.50.860.670.660.650.620.440.690.190.58-0.050.89-0.13-0.050.60.53-0.670.740.560.920.690.720.370.540.47
0.870.860.940.890.890.620.090.88-0.470.830.260.8-0.320.260.89-0.09-0.670.850.940.840.840.870.810.890.68
-0.150.170.00.110.040.440.09-0.130.44-0.20.510.130.510.510.210.850.230.02-0.130.41-0.060.03-0.20.27-0.05
0.820.90.970.840.870.690.88-0.13-0.40.94-0.080.89-0.48-0.080.81-0.11-0.770.910.970.830.910.910.720.750.69
-0.73-0.22-0.49-0.36-0.420.19-0.470.44-0.4-0.46-0.38-0.110.19-0.38-0.540.730.14-0.32-0.55-0.11-0.52-0.35-0.78-0.56-0.36
0.780.90.940.90.940.580.83-0.20.94-0.460.040.88-0.70.040.84-0.26-0.60.960.930.730.830.960.630.780.68
0.240.130.170.30.26-0.050.260.51-0.08-0.380.040.00.161.00.510.020.450.140.070.180.060.180.220.59-0.05
0.70.990.880.890.90.890.80.130.89-0.110.880.0-0.510.00.790.15-0.710.960.810.910.830.950.530.720.64
-0.29-0.48-0.43-0.56-0.61-0.13-0.320.51-0.480.19-0.70.16-0.510.16-0.330.520.26-0.62-0.45-0.14-0.29-0.62-0.12-0.26-0.37
0.240.130.170.30.26-0.050.260.51-0.08-0.380.041.00.00.160.510.020.450.140.070.180.060.180.220.59-0.05
0.830.870.930.890.910.60.890.210.81-0.540.840.510.79-0.330.51-0.04-0.380.880.860.830.810.90.710.990.59
-0.340.11-0.11-0.11-0.150.53-0.090.85-0.110.73-0.260.020.150.520.02-0.040.06-0.06-0.230.36-0.13-0.09-0.38-0.04-0.13
-0.67-0.66-0.65-0.56-0.55-0.67-0.670.23-0.770.14-0.60.45-0.710.260.45-0.380.06-0.6-0.7-0.64-0.77-0.59-0.65-0.33-0.6
0.770.980.940.940.970.740.850.020.91-0.320.960.140.96-0.620.140.88-0.06-0.60.880.850.841.00.60.830.63
0.870.860.980.870.890.560.94-0.130.97-0.550.930.070.81-0.450.070.86-0.23-0.70.880.780.90.890.80.830.73
0.710.930.870.810.790.920.840.410.83-0.110.730.180.91-0.140.180.830.36-0.640.850.780.840.840.590.80.52
0.920.860.920.820.820.690.84-0.060.91-0.520.830.060.83-0.290.060.81-0.13-0.770.840.90.840.840.860.780.62
0.790.970.940.960.980.720.870.030.91-0.350.960.180.95-0.620.180.9-0.09-0.591.00.890.840.840.620.850.67
0.970.60.770.640.650.370.81-0.20.72-0.780.630.220.53-0.120.220.71-0.38-0.650.60.80.590.860.620.720.57
0.820.820.890.870.880.540.890.270.75-0.560.780.590.72-0.260.590.99-0.04-0.330.830.830.80.780.850.720.55
0.630.650.670.660.740.470.68-0.050.69-0.360.68-0.050.64-0.37-0.050.59-0.13-0.60.630.730.520.620.670.570.55
Click cells to compare fundamentals

Bioventus Account Relationship Matchups

Bioventus fundamental ratios Accounts

201920202021202220232024 (projected)
Common Stock Shares Outstanding56.8M56.8M59.5M61.4M62.6M63.5M
Total Assets472.4M494.5M1.2B1.4B810.9M788.8M
Short Long Term Debt Total198.0M188.4M357.7M418.1M394.8M290.3M
Other Current Liab15.6M98.8M134.3M231.7M119.9M86.9M
Total Current Liabilities89.0M122.6M180.9M304.0M175.5M148.1M
Total Stockholder Equity143.0M142.2M458.9M316.6M173.6M240.5M
Property Plant And Equipment Net19.8M21.8M40.2M45.0M50.0M27.7M
Current Deferred Revenue57.0M99.2M142.3M4.7M5.5M5.2M
Net Debt133.4M101.5M313.7M386.3M357.9M245.3M
Retained Earnings(141.7M)(144.5M)(6.6M)(165.3M)(321.5M)(305.5M)
Accounts Payable6.4M4.4M16.9M36.7M23.0M15.1M
Cash64.5M86.8M43.9M31.8M37.0M45.0M
Non Current Assets Total289.4M282.7M962.8M1.1B542.9M576.9M
Non Currrent Assets Other3.3M19.4M50M(154.0M)3.1M3.3M
Cash And Short Term Investments64.5M86.8M43.9M31.8M37.0M45.0M
Net Receivables85.1M88.3M125.0M136.6M123.0M100.7M
Liabilities And Stockholders Equity472.4M494.5M1.2B1.4B810.9M788.8M
Non Current Liabilities Total237.8M227.7M511.2M728.3M414.3M379.4M
Inventory27.3M29.1M61.7M85.4M91.3M52.8M
Other Current Assets6.1M7.6M32.4M21.1M16.7M13.7M
Other Stockholder Equity(168M)1.9M465.3M490.6M494.3M519.0M
Total Liab326.8M350.3M692.1M1.0B589.8M527.5M
Property Plant And Equipment Gross19.8M21.8M40.2M45.0M90.5M95.0M
Total Current Assets183.0M211.8M263.1M272.6M268.0M212.0M
Accumulated Other Comprehensive Income(465K)1.6M179K(110K)794K833.7K
Short Term Debt10M17.0M21.5M33.1M27.8M22.0M
Intangible Assets216.5M191.7M695.2M1.0B482.4M475.1M
Common Stock285.1M285.2M75K78K79K75.1K
Long Term Debt188.0M173.4M339.6M385.0M367.0M301.1M
Net Invested Capital340.9M330.6M816.6M734.6M568.4M574.1M
Long Term Investments3.3M19.4M29.3M2.6M3.0M2.9M
Short Long Term Debt10M15M18.0M33.1M27.8M20.0M
Capital Stock285.1M285.2M75K78K79K75.1K
Non Current Liabilities Other20.7M21.7M38.1M110.0M46.1M44.4M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Bioventus Stock Analysis

When running Bioventus' price analysis, check to measure Bioventus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioventus is operating at the current time. Most of Bioventus' value examination focuses on studying past and present price action to predict the probability of Bioventus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioventus' price. Additionally, you may evaluate how the addition of Bioventus to your portfolios can decrease your overall portfolio volatility.